High‐resolution NMR spectroscopy of cerebral white matter in multiple sclerosis

Multiple sclerosis (MS) lesions have been shown by conventional methods to have major alterations in water and myelin lipid contents. To characterize these abnormalities more efficiently, NMR spectroscopy was used to evaluate water content by measuring relaxation times at 0.5 and 2.0 T. Subsequently, cholesterol content was obtained by using 1H NMR spectroscopy, while 31P NMR spectroscopy allowed measurement of the four main phospholipids and the inorganic phosphate concentrations in normal and pathological cerebral white matter samples. The relaxation times were significantly prolonged in MS lesions relative to normal white matter. Measured in different sample types, T 1 and T2 times increased with water content. Moreover, the T2 of normal‐appearing white matter was considerably lengthened. Analysis of white matter lipid composition using this method gave accurate values, which showed a significant decrease in phospholipids and cholesterol content in MS samples. © 1990 Academic Press, Inc.

[1]  P A Rinck,et al.  The effect of aging and storage conditions on excised tissues as monitored by longitudinal relaxation dispersion profiles , 1989, Magnetic resonance in medicine.

[2]  D. Marinier,et al.  Phosphorus NMR analysis of human white matter in mixed non-ionic detergent micelles. , 1988, Journal of lipid research.

[3]  J. Olesen,et al.  In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis , 1988, Magnetic resonance in medicine.

[4]  R L Kamman,et al.  Nuclear magnetic resonance relaxation in experimental brain edema: Effects of water concentration, protein concentration, and temperature , 1988, Magnetic resonance in medicine.

[5]  P. Renshaw,et al.  In vivo 31P NMR spectroscopy of agonist‐stimulated phosphatidylinositol metabolism in cat brain , 1987, Magnetic resonance in medicine.

[6]  R. Herndon,et al.  Use of magnetic resonance imaging in the diagnosis of multiple sclerosis. Policy statement of the National Multiple Sclerosis Society, New York , 1986 .

[7]  D. MacManus,et al.  Magnetic resonance imaging in clinically isolated lesions of the brain stem. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[8]  B. Chance,et al.  31P NMR detection of mobile dog brain phospholipids , 1986, Magnetic resonance in medicine.

[9]  J. Fazakerley,et al.  Multiple sclerosis, viruses and glycolipids , 1986, Nature.

[10]  H C Charles,et al.  Quantification of contrast in clinical MR brain imaging at high magnetic field. , 1985, Investigative radiology.

[11]  J. Ford,et al.  Magnetic resonance imaging in multiple sclerosis: results in 32 cases. , 1985, AJNR. American journal of neuroradiology.

[12]  L. Bolinger,et al.  Phosphorylethanolamine ‐ the major constituent of the phosphomonoester peak observed by 31P‐NMR on developing dog brain , 1984, FEBS letters.

[13]  C. Partain,et al.  Magnetic resonance imaging of multiple sclerosis: a study of pulse-technique efficacy. , 1984, AJR. American journal of roentgenology.

[14]  R. Vré,et al.  Biomedical implications of the relaxation behaviour of water related to NMR imaging , 1984 .

[15]  T. Foster,et al.  A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision, and age. , 1984, Medical physics.

[16]  R. Yu,et al.  Analysis of brain lipids by high performance thin-layer chromatography and densitometry. , 1983, Journal of lipid research.

[17]  L. Kaufman,et al.  Nuclear magnetic resonance imaging in multiple sclerosis , 1983, Annals of neurology.

[18]  E. Dennis,et al.  Solubilization of phospholipids by detergents. Structural and kinetic aspects. , 1983, Biochimica et biophysica acta.

[19]  A. S. Hall,et al.  NUCLEAR MAGNETIC RESONANCE IMAGING OF THE BRAIN IN MULTIPLE SCLEROSIS , 1981, The Lancet.

[20]  J. Ferretti,et al.  Selection of optimum parameters for pulse Fourier transform nuclear magnetic resonance , 1979 .

[21]  G. Feigenson,et al.  Phosphorus NMR analysis of phospholipids in detergents. , 1979, Journal of lipid research.

[22]  N. Baumann,et al.  Microanalysis of brain lipids: multiple two-dimensional thin-layer chromatography. , 1978, Journal of lipid research.

[23]  A. Helenius,et al.  Solubilization of membranes by detergents. , 1975, Biochimica et biophysica acta.

[24]  K. Suzuki,et al.  Myelin in multiple sclerosis. Composition of myelin from normal-appearing white matter. , 1973, Archives of neurology.

[25]  L. Eng,et al.  ON THE COMPOSITION OF HUMAN MYELIN * , 1967, Journal of neurochemistry.

[26]  J. Cumings Lipid chemistry of the brain in demyelinating diseases. , 1955, Brain : a journal of neurology.

[27]  R L Kamman,et al.  Changes of relaxation times T1 and T2 in rat tissues after biopsy and fixation. , 1985, Magnetic resonance imaging.

[28]  K. Go,et al.  Proton spin relaxation studies of fatty tissue and cerebral white matter. , 1984, Magnetic resonance imaging.

[29]  M Brant-Zawadzki,et al.  Cerebral abnormalities: use of calculated T1 and T2 magnetic resonance images for diagnosis. , 1984, Radiology.

[30]  M E Moseley,et al.  Proton nuclear magnetic resonance spectroscopy of normal and edematous brain tissue in vitro: changes in relaxation during tissue storage. , 1984, Magnetic resonance imaging.

[31]  Cedric S. Raine Myelin , 1984, Springer US.

[32]  F. Kasler Quantitative Analysis by NMR Spectroscopy . , 1973 .

[33]  K. Misulis,et al.  DEMYELINATING diseases. , 1952, Lancet.